Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 4 of 4 entries
View as:

Long-term Follow-up of Study Participant Treated With Lentiviral-Based Genetically Modified Autologous Cell Product ,AGT103-T

Phase: N/A Priority: Normal
NCT ID: NCT05529342 Org: User:
Start: 08/29/22 End: 09/29/38 Due: 09/29/39

An Antiretroviral Treatment Interruption (ATI) Study to Evaluate the Impact of Genetically Modified Autologous Cells (AGT103-T) to Suppress Human Immunodeficiency Virus Replication in the Absence of Antiretroviral Therapy

Phase: N/A Priority: Normal
NCT ID: NCT05540964 Org: User:
Start: 07/19/22 End: 07/19/25 Due: 07/19/26

Developing a Functional Cure for HIV Disease: Clinical Specimen Collection From HIV Positive Individuals

Phase: N/A Priority: Normal
NCT ID: NCT03215004 Org: User:
Start: 07/25/17 End: 02/07/21 Due: 02/07/22

Study to Evaluate the Safety of a Gene and Cell Therapy Product in Participants With HIV That is Well-Controlled on Antiretroviral Therapy

Phase: N/A Priority: Normal
NCT ID: NCT04561258 Org: User:
Start: 10/12/20 End: 11/21/22 Due: 11/21/23